Abbott’s ‘Dominant’ FreeStyle Libre Targeted in Patent Suit (1)

Abbott Laboratories’ billions of dollars in revenue from its FreeStyle Libre glucose-monitoring products are in the crosshairs of Gentag Inc., which alleges the healthcare giant used patented technology disclosed in a 2006 meeting with Gentag’s founder to “put them in a dominant position in the marketplace.”

Gentag and its patent-holding unit, Altivera LLC, say the company’s founder, John Peeters, met with Abbott representatives under a non-disclosure agreement to discuss the potential licensing of Gentag’s patent portfolio, according to a complaint filed Thursday in the US District Court for the Northern District of Illinois.

Peeters also is an inventor whom ...